Pakistan vs Saint Barthélemy: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Pakistan
0.2%
in 2024
Saint Barthélemy
0.2%
in 2024
Pakistan rank
78th
Saint Barthélemy rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Pakistan
- Saint Barthélemy
How they compare
Pakistan currently reports 0.2% against 0.2% in Saint Barthélemy, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Saint Barthélemy ahead.
Pakistan ranks 78th and Saint Barthélemy ranks 78th of 215 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Pakistan | Saint Barthélemy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.1% | Pakistan |
| 2020s | 0.2% | 0.2% | 0.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Pakistan or Saint Barthélemy?
- Pakistan, at 0.2% against 0.2% in Saint Barthélemy as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Pakistan and Saint Barthélemy?
- 0.0%, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and Saint Barthélemy?
- 10 years are reported by both, from 2015 to 2024.
- How do Pakistan and Saint Barthélemy rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Pakistan ranks 78th and Saint Barthélemy ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.